08:55 AM EDT, 04/03/2025 (MT Newswires) -- Health care stocks were leaning lower premarket Thursday, with The Health Care Select Sector SPDR Fund (XLV) down 0.6% and the iShares Biotechnology ETF (IBB) 2.9% lower.

RxSight ( RXST ) shares were down past 31% after the company lowered its 2025 revenue guidance range to between $160 million and $175 million from its previous projection of $185 million to $197 million.